This has been linked to lifestyle changes, metabolic diseases, and obesity, with cases increasingly being reported in women ...

The addition of radiation to chemotherapy did not improve overall survival in patients with locally advanced endometrial ...

Part of that spike is due to rising rates of cancers that affect primarily women, including breast cancer and endometrial ...

"The lack of a significant link between AmygA and LN metastasis in premenopausal women suggests that menopausal status may ...

The risk and incidence of cancer among people under 50 is also on the rise, according to American Cancer Society.

Cancer rates for young women are sharply rising, with women under 50 more likely to develop cancer than their male ...

Meanwhile, J&J has claimed EU approval for its combination of EGFRxMET bispecific antibody Rybrevant (amivantamab) with third ...

GSK’s Jemperli is designed to help the body’s immune system find and attack cancer cells, and is already approved in the EU ...

GSK's Jemperli wins EU approval for broader use in advanced endometrial cancer, showing improved survival and significant ...

GSK (GSK) announced the European Commission has approved Jemperli, or dostarlimab, in combination with chemotherapy for first-line treatment of ...